These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31401402)

  • 41. Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs.
    Simpson JA; Lovecky D; Kogan J; Vetter LA; Yohrling GJ
    J Huntingtons Dis; 2016 Dec; 5(4):395-403. PubMed ID: 27983566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electroconvulsive Therapy (ECT) for Refractory Psychiatric Symptoms in Huntington's Disease: A Case Series and Review of the Literature.
    Adrissi J; Nadkarni NA; Gausche E; Bega D
    J Huntingtons Dis; 2019; 8(3):291-300. PubMed ID: 31322579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factor analysis of the hospital anxiety and depression scale among a Huntington's disease population.
    Dale M; Maltby J; Martucci R; Shimozaki S;
    Mov Disord; 2015 Dec; 30(14):1954-60. PubMed ID: 26443751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emotion Evaluation and Social Inference Impairments in Huntington's Disease.
    Philpott AL; Andrews SC; Staios M; Churchyard A; Fisher F
    J Huntingtons Dis; 2016 May; 5(2):175-83. PubMed ID: 27163947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identifying Clinically Significant Irritability in Early Childhood.
    Wiggins JL; Briggs-Gowan MJ; Estabrook R; Brotman MA; Pine DS; Leibenluft E; Wakschlag LS
    J Am Acad Child Adolesc Psychiatry; 2018 Mar; 57(3):191-199.e2. PubMed ID: 29496128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors of suicidal ideation in Huntington's disease: literature review and data from Enroll-HD.
    Honrath P; Dogan I; Wudarczyk O; Görlich KS; Votinov M; Werner CJ; Schumann B; Overbeck RT; Schulz JB; Landwehrmeyer BG; Gur RE; Habel U; Reetz K;
    J Neurol; 2018 Nov; 265(11):2548-2561. PubMed ID: 30167880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cognitive and psychiatric characterization of patients with Huntington's disease and their at-risk relatives.
    Soliveri P; Monza D; Piacentini S; Paridi D; Nespolo C; Gellera C; Mariotti C; Albanese A; Girotti F
    Neurol Sci; 2002 Sep; 23 Suppl 2():S105-6. PubMed ID: 12548365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The functional implications of motor, cognitive, psychiatric, and social problem-solving states in Huntington's disease.
    Van Liew C; Gluhm S; Goldstein J; Cronan TA; Corey-Bloom J
    Psychiatry; 2013; 76(4):323-35. PubMed ID: 24299091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The structure of mental health symptoms in Huntington's disease: Comparisons with healthy populations.
    Maltby J; Ovaska-Stafford N; Gunn S
    J Clin Exp Neuropsychol; 2021 Sep; 43(7):737-752. PubMed ID: 34906020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Excessive response to provocation rather than disinhibition mediates irritable behaviour in Huntington's disease.
    McLauchlan DJ; Linden DEJ; Rosser AE
    Front Neurosci; 2022; 16():993357. PubMed ID: 36643017
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific psychiatric manifestations among preclinical Huntington disease mutation carriers.
    Marshall J; White K; Weaver M; Flury Wetherill L; Hui S; Stout JC; Johnson SA; Beristain X; Gray J; Wojcieszek J; Foroud T
    Arch Neurol; 2007 Jan; 64(1):116-21. PubMed ID: 17210818
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The Severe Chronic Irritability Concept: A clinical dimension to consider in child and adolescent].
    Fourneret P; Desombre H
    Encephale; 2017 Apr; 43(2):187-191. PubMed ID: 27745722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease.
    Zappacosta B; Monza D; Meoni C; Austoni L; Soliveri P; Gellera C; Alberti R; Mantero M; Penati G; Caraceni T; Girotti F
    Arch Neurol; 1996 Jun; 53(6):493-7. PubMed ID: 8660149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation of self-report depression rating scales in Huntington's disease.
    De Souza J; Jones LA; Rickards H
    Mov Disord; 2010 Jan; 25(1):91-6. PubMed ID: 19908314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Irritability: definition, assessment and associated factors.
    Snaith RP; Taylor CM
    Br J Psychiatry; 1985 Aug; 147():127-36. PubMed ID: 3840045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Practitioner Review: Definition, recognition, and treatment challenges of irritability in young people.
    Stringaris A; Vidal-Ribas P; Brotman MA; Leibenluft E
    J Child Psychol Psychiatry; 2018 Jul; 59(7):721-739. PubMed ID: 29083031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimising mobility outcome measures in Huntington's disease.
    Busse M; Quinn L; Khalil H; McEwan K
    J Huntingtons Dis; 2014; 3(2):175-88. PubMed ID: 25062860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of the Music Therapy Assessment Tool for Advanced Huntington's Disease: A Pilot Validation Study.
    O'Kelly J; Bodak R
    J Music Ther; 2016; 53(3):232-56. PubMed ID: 27358245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Irritability associated with major depressive episodes: its relationship with mood disorders and temperament].
    Parneix M; Pericaud M; Clement JP
    Turk Psikiyatri Derg; 2014; 25(2):106-13. PubMed ID: 24936757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropsychiatric aspects of Huntington's disease.
    Paulsen JS; Ready RE; Hamilton JM; Mega MS; Cummings JL
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):310-4. PubMed ID: 11511702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.